- Clinical Interests
- Pituitary disease
- Adrenal disorders
- Endocrine disorders in HIV
- Medical Education
- MD, Columbia University College of Physicians and Surgeons
- Residency, New York Presbyterian Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Diabetes & Metabolism
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
Janet Lo, M.D., M.MSc. is a clinician in the Neuroendocrine Clinical Center and a faculty member in the Neuroendocrine Unit at the Massachusetts General Hospital, and an Assistant Professor of Medicine at Harvard Medical School. She is a clinical researcher who studies endocrine disease, cardiovascular disease and inflammation. She is also a clinician with a focus on pituitary disease and other endocrine diseases. Awards in recognition of her work have included the MGH Claflin Award and NIH Career Development Award. She is the Principal Investigator of a NIH Research Project Grant (RO1) and is an author of more than 32 peer-reviewed publications.
Lo J, You S, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S. Low Dose Physiologic Growth Hormone in HIV Patients with Abdominal Fat Accumulation: A Randomized Controlled Trial. JAMA 300(5): 509-519, 2008.
Nachtigall LB, Valassi E, Lo J, McCarty D, Passeri J, Biller BM, Miller KK, Utz A, Grinspoon S, Lawson EA, Klibanski A. Gender Effects on Cardiac Valvular Function in Hyperprolactinaemic Patients Receiving Cabergoline: a Retrospective Study. Clinical Endocrinology 2009.
Korner J, Lo J, Freda P, Wardlaw S, Treatment with Cabergoline is associated with weight loss in patients with hyperprolactinemia. Obesity Research. 2003;11(2):311-312.
Lo J, Abbara S, Shturman L, Soni A, Rocha-Filho J, Wei J, Nasir K, Grinspoon S. Increased Prevalence of Subclinical Coronary Atherosclerosis Detected by Coronary Computed Tomography Angiography in HIV-Infected Men. AIDS 24(2):243-53, 2010.
A Massachusetts General Hospital study has found that relatively young men with longstanding HIV infection and minimal cardiac risk factors had significantly more coronary atherosclerotic plaques - some involving serious arterial blockage - than did uninfected men with similar cardiovascular risk.
Zero Emerson Place
Boston MA, 02114-2217